miR-199a-5p	NN
Is	VBZ
upregulated	VBN
during	IN
fibrogenic	JJ
response	NN
to	TO
tissue	NN
injury	NN
and	CC
mediates	VBZ
TGFbeta-induced	JJ
lung	NN
fibroblast	NN
activation	NN
by	IN
targeting	VBG
caveolin-1	NN
.	.

As	IN
miRNAs	NNS
are	VBP
associated	VBN
with	IN
normal	JJ
cellular	JJ
processes	NNS
,	,
deregulation	NN
of	IN
miRNAs	NNP
is	VBZ
thought	VBN
to	TO
play	VB
a	DT
causative	JJ
role	NN
in	IN
many	JJ
complex	JJ
diseases	NNS
.	.

Nevertheless	RB
,	,
the	DT
precise	JJ
contribution	NN
of	IN
miRNAs	NNS
in	IN
fibrotic	JJ
lung	NN
diseases	NNS
,	,
especially	RB
the	DT
idiopathic	JJ
form	NN
(	(
IPF	NN
)	)
,	,
remains	VBZ
poorly	RB
understood	VBN
.	.

Given	VBN
the	DT
poor	JJ
response	NN
rate	NN
of	IN
IPF	NN
patients	NNS
to	TO
current	JJ
therapy	NN
,	,
new	JJ
insights	NNS
into	IN
the	DT
pathogenic	JJ
mechanisms	NNS
controlling	VBG
lung	NN
fibroblasts	NNS
activation	NN
,	,
the	DT
key	JJ
cell	NN
type	NN
driving	VBG
the	DT
fibrogenic	JJ
process	NN
,	,
are	VBP
essential	JJ
to	TO
develop	VB
new	JJ
therapeutic	JJ
strategies	NNS
for	IN
this	DT
devastating	VBG
disease	NN
.	.

To	TO
identify	VB
miRNAs	NNS
with	IN
potential	JJ
roles	NNS
in	IN
lung	NN
fibrogenesis	NN
,	,
we	PRP
performed	VBD
a	DT
genome-wide	JJ
assessment	NN
of	IN
miRNA	NN
expression	NN
in	IN
lungs	NNS
from	IN
two	CD
different	JJ
mouse	NN
strains	NNS
known	VBN
for	IN
their	PRP$
distinct	JJ
susceptibility	NN
to	TO
develop	VB
lung	NN
fibrosis	NN
after	IN
bleomycin	NN
exposure	NN
.	.

This	DT
led	VBD
to	TO
the	DT
identification	NN
of	IN
miR-199a-5p	NN
as	IN
the	DT
best	JJS
miRNA	NN
candidate	NN
associated	VBN
with	IN
bleomycin	NN
response	NN
.	.

Importantly	RB
,	,
miR-199a-5p	NN
pulmonary	JJ
expression	NN
was	VBD
also	RB
significantly	RB
increased	VBN
in	IN
IPF	NN
patients	NNS
(	(
94	CD
IPF	NN
versus	CC
83	CD
controls	NNS
)	)
.	.

In	IN
particular	JJ
,	,
levels	NNS
of	IN
miR-199a-5p	NN
were	VBD
selectively	RB
increased	VBN
in	IN
myofibroblasts	NNS
from	IN
injured	JJ
mouse	NN
lungs	NNS
and	CC
fibroblastic	JJ
foci	NNS
,	,
a	DT
histologic	JJ
feature	NN
associated	VBN
with	IN
IPF	NN
.	.

Therefore	RB
,	,
miR-199a-5p	NN
profibrotic	JJ
effects	NNS
were	VBD
further	RB
investigated	VBN
in	IN
cultured	VBN
lung	NN
fibroblasts	NNS
:	:
miR-199a-5p	NN
expression	NN
was	VBD
induced	VBN
upon	IN
TGFb	NN
exposure	NN
,	,
and	CC
ectopic	JJ
expression	NN
of	IN
miR-199a-5p	NN
was	VBD
sufficient	JJ
to	TO
promote	VB
the	DT
pathogenic	JJ
activation	NN
of	IN
pulmonary	JJ
fibroblasts	NNS
including	VBG
proliferation	NN
,	,
migration	NN
,	,
invasion	NN
,	,
and	CC
differentiation	NN
into	IN
myofibroblasts	NNS
.	.

In	IN
addition	NN
,	,
we	PRP
demonstrated	VBD
that	IN
miR-199a-5p	NN
is	VBZ
a	DT
key	JJ
effector	NN
of	IN
TGFb	NN
signaling	NN
in	IN
lung	NN
fibroblasts	NNS
by	IN
regulating	VBG
CAV1	NN
,	,
a	DT
critical	JJ
mediator	NN
of	IN
pulmonary	JJ
fibrosis	NN
.	.

Remarkably	RB
,	,
aberrant	JJ
expression	NN
of	IN
miR-199a-5p	NN
was	VBD
also	RB
found	VBN
in	IN
unilateral	JJ
ureteral	JJ
obstruction	NN
mouse	NN
model	NN
of	IN
kidney	NN
fibrosis	NN
,	,
as	RB
well	RB
as	IN
in	IN
both	DT
bile	NN
duct	NN
ligation	NN
and	CC
CCl4-induced	JJ
mouse	NN
models	NNS
of	IN
liver	NN
fibrosis	NN
,	,
suggesting	VBG
that	IN
dysregulation	NN
of	IN
miR-199a-5p	NN
represents	VBZ
a	DT
general	JJ
mechanism	NN
contributing	VBG
to	TO
the	DT
fibrotic	JJ
process	NN
.	.

MiR-199a-5p	NN
thus	RB
behaves	VBZ
as	IN
a	DT
major	JJ
regulator	NN
of	IN
tissue	NN
fibrosis	NN
with	IN
therapeutic	JJ
potency	NN
to	TO
treat	VB
fibroproliferative	JJ
diseases	NNS
.	.

